- Home
- SPXX vs SOPH Comparison
SPXX vs SOPH Comparison
Compare SPXX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPXX
- SOPH
- Stock Information
- Founded
- SPXX 2004
- SOPH 2011
- Country
- SPXX United States
- SOPH Switzerland
- Employees
- SPXX N/A
- SOPH N/A
- Industry
- SPXX Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPXX Finance
- SOPH Health Care
- Exchange
- SPXX Nasdaq
- SOPH Nasdaq
- Market Cap
- SPXX 294.7M
- SOPH 247.0M
- IPO Year
- SPXX N/A
- SOPH 2021
- Fundamental
- Price
- SPXX $16.89
- SOPH $3.40
- Analyst Decision
- SPXX
- SOPH Strong Buy
- Analyst Count
- SPXX 0
- SOPH 3
- Target Price
- SPXX N/A
- SOPH $7.00
- AVG Volume (30 Days)
- SPXX 51.3K
- SOPH 21.9K
- Earning Date
- SPXX 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- SPXX 7.55%
- SOPH N/A
- EPS Growth
- SPXX N/A
- SOPH N/A
- EPS
- SPXX N/A
- SOPH N/A
- Revenue
- SPXX N/A
- SOPH $64,938,000.00
- Revenue This Year
- SPXX N/A
- SOPH $7.70
- Revenue Next Year
- SPXX N/A
- SOPH $20.61
- P/E Ratio
- SPXX N/A
- SOPH N/A
- Revenue Growth
- SPXX N/A
- SOPH 20.14
- 52 Week Low
- SPXX $13.57
- SOPH $2.70
- 52 Week High
- SPXX $16.05
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- SPXX 61.69
- SOPH 44.10
- Support Level
- SPXX $16.77
- SOPH $3.22
- Resistance Level
- SPXX $16.87
- SOPH $3.66
- Average True Range (ATR)
- SPXX 0.11
- SOPH 0.20
- MACD
- SPXX 0.01
- SOPH 0.01
- Stochastic Oscillator
- SPXX 93.73
- SOPH 58.60
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio (with a 55% long-term target) in an effort to enhance the Fund's risk-adjusted returns.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.